SiteOne Landscape Supply Fiscal Q2 Net Income, Net Sales Increase-March 2024-www.financetom.com

SiteOne Landscape Supply Fiscal Q2 Net Income, Net Sales Increase

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

SiteOne Landscape Supply Fiscal Q2 Net Income, Net Sales Increase

Jul 30, 2025 4:06 AM

06:39 AM EDT, 07/30/2025 (MT Newswires) -- SiteOne Landscape Supply ( SITE ) reported Fiscal Q2 net income Wednesday of $2.86 per diluted share, up from $2.63 a year earlier.

Four analysts polled by FactSet expected $2.82 per share.

Net sales for the quarter ended June 29 were $1.46 billion, up from $1.41 billion a year earlier.

Analysts surveyed by FactSet expected $1.47 billion.

Previous page： What's Driving The Weakness In Broadcom Stock Thursday? Next page： Google Translate Introduces AI Features

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Driving The Weakness In Broadcom Stock Thursday?

Mar 11, 2026

Broadcom Inc ( AVGO ) shares are dropping on Thursday as a sector‑wide sell‑off triggered by Nvidia Corp’s post‑earnings decline weighs on chip stocks. Broadcom ( AVGO ) shares are sliding. Why is AVGO stock falling? Sector Pressure Following Nvidia's Sell‑Off The weakness in Broadcom ( AVGO ) is likely being driven by a broader pullback across the semiconductor sector....

Google Translate Introduces AI Features

Mar 11, 2026

02:27 PM EST, 02/26/2026 (MT Newswires) -- Alphabet's (GOOGL, GOOG) Google ( GOOG ) on Thursday introduced new artificial intelligence-powered features in Google Translate to explore linguistic nuances. Google Translate, using Gemini's multilingual capabilities, now offers multiple alternatives, which is particularly useful for translating idioms and more colloquial phrases, the tech giant said in a blog post. The new features...

Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients

Mar 11, 2026

Bristol Myers Squibb Co. ( BMY ) shares are down on Thursday as the company releases positive interim results from a Phase 3 trial of izalontamab brengitecan (Iza-bren), in collaboration with SystImmune Inc. This news comes as the broader market experienced mixed performance, with the Nasdaq slightly down while other indices showed modest gains. Breast Cancer Trial Data SystImmune’s parent...

BRIEF-TDE Group Files To Withdraw US IPO

Mar 11, 2026

Feb 26 (Reuters) - TDE GROUP: * TDE GROUP : FILES TO WITHDRAW US IPO Source text: ;)) ...